Details for New Drug Application (NDA): 050734
✉ Email this page to a colleague
The generic ingredient in IDAMYCIN PFS is idarubicin hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the idarubicin hydrochloride profile page.
Summary for 050734
Tradename: | IDAMYCIN PFS |
Applicant: | Pfizer |
Ingredient: | idarubicin hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 050734
Mechanism of Action | Topoisomerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 050734
Suppliers and Packaging for NDA: 050734
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
IDAMYCIN PFS | idarubicin hydrochloride | INJECTABLE;INJECTION | 050734 | NDA | Pfizer Laboratories Div Pfizer Inc | 0013-2576 | 0013-2576-05 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2576-05) / 5 mL in 1 VIAL, SINGLE-DOSE |
IDAMYCIN PFS | idarubicin hydrochloride | INJECTABLE;INJECTION | 050734 | NDA | Pfizer Laboratories Div Pfizer Inc | 0013-2576 | 0013-2576-91 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2576-91) / 5 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
Approval Date: | Feb 17, 1997 | TE: | AP | RLD: | Yes |
Complete Access Available with Subscription